Who is the quarterback of population health?

Stakeholders take different approaches to trying to deliver lasting wellness improvements
Nov 15, 2015 10:40 AM

Hedge fund still a big buyer of Healthways

North Tide takes stake past 12%
Nov 13, 2015 7:16 AM

Biggest Healthways investor goes on stock buying spree

Hedge fund grows stake to nearly 12%
Nov 6, 2015 11:28 AM

Analysts trim Healthways targets

Barrington Research analyst Michael Petusky has trimmed his price target for shares of Healthways to $13 from $18 following the population health services company’s quarterly report and the unveiling of a wide-ranging restructuring plan. Petusky still has Healthways at ‘outperform.’

Over at Barclays, Josh Raskin is still a little more guarded at ‘underweight.’ He also has cut his target for Healthways shares (Ticker: HWAY), which closed Tuesday at $11.48, to $12 from $15.

Nov 4, 2015 7:20 AM

Healthways to restructure, execs coming and going

Company streamlining divisions and selling subsidiary, expects $40M in write-downs
Oct 30, 2015 6:51 AM

New population health venture for Frist

Former Senator targeting Davidson County health and wellness
Sep 22, 2015 7:30 AM

Healthways, Hawaiian health insurer restructure, extend deal

8% of local company's employees will transfer to client's payroll
Sep 15, 2015 2:25 PM

Healthways adds three new partners to Ornish program

Healthways has landed three new contracts for the Dr. Ornish's Program for Reversing Heart Disease.

The Nashville company has partnered with Hawaii Pacific Health, KentuckyOne Health and The Heart Health Center, a provider group in St. Louis. Terms of the contracts were not released.

"The addition of our first large provider group demonstrates the breadth of demand for solutions that combat the root causes of the most serious diseases," Alfred Lumsdaine (pictured), Healthways interim CEO, said in a release. "The Ornish Reversal Program offers patients a powerful alternative to high-cost treatment such as surgery and offers hospitals and providers a proven solution that supports the transition to value-based care."

Healthways has licensed the Dr. Ornish program since 2013. Shares of Healthways (Ticker: HWAY) were up slightly to $11.99 Thursday. Year to date, they're down nearly 40 percent.

Sep 10, 2015 11:40 AM

Former Healthways COO wants $3M+ over firing

Michela says he was served papers after saying he wouldn't wait in line behind CEO-to-be Tramuto
Aug 25, 2015 7:03 AM

Ex-Healthways COO plans breach lawsuit

Two-stint company veteran wants to stop new CEO 'taking such actions against others'
Aug 20, 2015 2:09 PM